Overview Emmanuelle Trombe, Bertrand Delafaye and Louise Aberg advised a biopharmaceutical company on its acquisition of an innovative clinical stage drug candidate and a portfolio of other drug candidates for EUR 6.8 million plus capital interest. READ THE FULL ARTICLE
